Scientists reveal the gut’s hidden hydrogen engine and the way it stalls in Crohn’s disease

In a study recently published within the journal Natural microbiologyA global team of researchers used a multifaceted study that combined genomic, transcriptomic and biochemical analyzes to discover the fundamental driver of fermentative production of molecular hydrogen (H₂) in healthy individuals. The molecular H₂ cycle is a crucial metabolic process within the human gut, but the particular microbes and enzymes answerable for it remain unclear.

background

A long time of research have shown that the human intestine Microbiome is a busy metabolic reactor made up of trillions of microbes fermenting spent carbohydrates. This process ends in the production of energy, useful short-chain fatty acids, and enormous amounts of gases, including molecular hydrogen (H₂).

Conventionally viewed as an easy waste product, recent research has shown that molecular H₂ is an important food source for other microbes (so-called “hydrogenotrophs”), thereby making fermentation thermodynamically more favorable.

Dysbiosis, or imbalances in H₂ production and consumption, are increasingly related to serious health problems, starting with gas buildup in irritable bowel syndrome (IBS) to infections and even gastrointestinal cancer. As well as, it has been observed that some pathogens, corresponding to: B. “hijack” molecular H₂ to advertise their penetration into the intestine.

Unfortunately, despite its importance, the microbes and specific enzymes involved in H₂ production and metabolism are still unclear.

In regards to the study

The current study goals to handle this information gap and support future research and gastrointestinal interventions by utilizing a multi-pronged approach to elucidate the microbes and enzymes involved in H₂ production from the ecosystem level all the way down to the person enzyme.

The study involved several sequential steps: First, a large-scale computational evaluation of 300 stool metagenomes and 78 metatranscriptomes was carried out to elucidate the total spectrum of hydrogen-related genes present and energetic within the healthy human intestine. These results were validated using 102 mucous membranes biopsyEnriched metagenomes from 42 donors. Moreover, analyzes focused on samples from the terminal ileum, appendix, and rectum to verify consistency across all intestinal regions.

To point out that these genes are functional, the study then chosen 19 different species of bacteria from the human gut and grew them under anaerobic (oxygen-free) conditions to simulate gut conditions. Gas chromatography assays were used to accurately measure the quantity of H₂ gas produced by each bacterial isolate over time.

Finally, biochemical tests (on bacterial cell extracts) were carried out to elucidate the connection between H₂ production and pyruvate:ferredoxin oxidoreductase (PFOR) response, a central a part of fermentation. Particularly, PFOR substrates (pyruvate and CoA) and inhibitors were added to see how H₂ levels responded, supported by AlphaFold2 modeling, heterologous expression and spectroscopy/EPR Evidence confirming the ferredoxin-like domain and catalytic function of the enzyme.

Study results

Study results showed for the primary time that group B [FeFe]-Hydrogenase enzyme was by far probably the most dominant hydrogen-producing gene within the healthy human intestine. Abundance estimates revealed that group B genes were found on average 0.75 ± 0.25 copies per genome, roughly 7.5 times more abundant than the group A1 enzyme (0.10 ± 0.09 copies), previously considered the leading H₂ producer.

Activity assays supported these results and showed that group B genes were also probably the most highly transcribed (energetic) within the metatranscriptome. Unexpectedly, nevertheless, activity tests showed that , one of the crucial common genera within the intestine, is a significant user of group B enzymes and due to this fact a vital H₂ producer, a connection that had not been sufficiently recognized before.

Analyzes of the 19 bacterial isolates confirmed these results and showed that species encoding the group B gene, including seven different isolates, produced high levels of H₂ gas. In contrast, a species that doesn’t naturally lack any hydrogenase genes was observed not to supply H₂, consistent with the absence of detectable hydrogenase genes.

Essentially the most significant is the comparison of healthy individuals with 46 patients CD revealed that the “healthy” hydrogenase of group B was significantly depleted (P = 0.0023) and, particularly, was replaced by other enzymes: the hydrogenase of group A1 increased 2.8-fold (P = 6.6 × 10⁻⁷), the formate hydrogen lyase of group 4a (commonly present in ) increased 5.2-fold (P = 6.8 × 10⁻⁶) and the group 1d [NiFe]-Hydrogenase increased 2.6-fold (P = 3.8 × 10⁻⁵). Genes for respiratory H₂ oxidation, especially group 1d [NiFe]-Hydrogenases, also increased, supporting a restructured hydrogen economy within the inflamed intestine CD patients.

Expression also varied significantly between individuals and the collective [FeFe] The subgroups didn’t differ significantly CD and control samples, highlighting that these relationships are correlational and require further mechanistic investigation. Based on gene abundance and transcriptional data, respiratory hydrogenotrophs likely dominate intestinal H₂ consumption, although validation of activity levels remains to be needed.

Conclusions

The current study refines and consolidates the scientific understanding of a fundamental metabolic process within the human intestine and identifies group B [FeFe]-Hydrogenase as the first driver of fermentative H₂ production in healthy individuals, making the genus a key player.

This discovery opens latest avenues for understanding, diagnosing and potentially treating complex inflammatory bowel diseases through using interventions that concentrate on the gut microbiome. It also suggests that respiratory hydrogenotrophs are the fundamental consumers of H₂, highlighting the complexity of microbial energy flow within the intestinal ecosystem.